Registry Developing Tools to Measure Overweight and Obesity Impact
Builds tools measuring severity, quality of life and costs in adults with overweight or obesity.
Plain-language title generated from the registry record
Registry title: Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Key facts
- Where
- Milton Keynes, United KingdomSee the site
Where in United Kingdom
- Online recruitmentMilton Keynes, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medialis Ltd.
- Trial code
- NCT07229027
- Record updated
- 14 November 2025
- Original description
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.Read full original descriptionShow less
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Inclusion: Patient group; Patient is aged ≥18 years at the time of survey completion; Patient has a BMI over 25 (self-reported); Patient is willing to participate in all study activities; Patient is able to read, write, and converse in English; Healthcare professional participant must meet the following criteria for inclusion in the study:; HCP is aged ≥18 years at the time of survey completion; HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25; HCP is willing to participate in all study activities; HCP is able to read, write, and converse in English.
Exclusion: A participant who meets any of the following criteria will be excluded from the study:; Participants do not have the cognitive capacity to provide informed consent; Participants with severe co-morbidity that might affect study participation.